Company intelligence / Profile preview

Nova Eye Medical

Fremont, California, United Statesnova-eye.com ↗

Ownership: Private
Employees: ~301
Development stage: Commercial

Overview

Nova Eye Medical has commercialized a portfolio of proprietary ophthalmic surgical devices for the treatment of glaucoma and age-related macular degeneration. Its iTrack™ Advance microcatheter system for canaloplasty has FDA clearance and CE Mark for open-angle glaucoma. The Molteno3® drainage device addresses complex glaucomas. The company also markets the 2RT laser for early intervention in age-related macular degeneration. Clinical results support improved intraocular pressure control with minimally invasive approaches.

Therapeutic areas: Ophthalmology
Modalities: DeviceSurgical deviceLaser therapy
Industry: Surgical Medical Devices

Partnerships

Collaborations with teaching institutions, researchers, ophthalmic surgeonsglobal network of over 50 distribution partners

Beyond the preview

Go deeper on Nova Eye Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nova Eye Medical.

Explore the full profile